p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection

Manoj B Menon1, Julia Gropengießer2, Jessica Fischer1

  • 1Institute of Cell Biochemistry, Hannover Medical School, Hannover 30625, Germany.

Nature Cell Biology
|September 19, 2017
PubMed

Insights

MAPKAP kinase-2 (MK2) phosphorylates Receptor-interacting protein kinase-1 (RIPK1), inhibiting cell death pathways. This crucial checkpoint in inflammation and infection determines bacteria-host cell interaction outcomes.

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Receptor-interacting protein kinase-1 (RIPK1) is a key regulator of cell death.
  • Understanding RIPK1 regulation is vital for controlling inflammatory and infectious diseases.

Purpose of the Study:

  • To identify direct substrates of MAPKAP kinase-2 (MK2).
  • To elucidate the role of MK2-mediated RIPK1 phosphorylation in cellular responses to inflammation and infection.

Main Methods:

  • Phosphoproteomic screening of LPS-treated macrophages and stress-stimulated embryonic fibroblasts.
  • Co-immunoprecipitation to study protein interactions.
  • Analysis of cell death pathways (apoptosis and necroptosis) in response to stimuli and pathogen infection.

Main Results:

  • RIPK1 was identified as a direct substrate of MK2.
  • MK2 phosphorylates RIPK1 at Ser321/336 in response to pro-inflammatory stimuli (TNF, LPS) and Yersinia enterocolitica infection.
  • MK2 phosphorylation of RIPK1 inhibits its autophosphorylation, prevents its incorporation into cytotoxic complexes, and suppresses RIPK1-dependent apoptosis and necroptosis.
  • In Yersinia-infected macrophages, MK2-mediated RIPK1 phosphorylation protects against apoptosis, a process antagonized by Yersinia outer protein P (YopP).

Conclusions:

  • MK2 phosphorylation of RIPK1 is a critical regulatory mechanism controlling cell fate during inflammation and infection.
  • This pathway is essential for determining the outcome of bacteria-host cell interactions and presents a potential therapeutic target.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K